Aletho News

ΑΛΗΘΩΣ

Cholesterol lowering is fraud says Cardiologist

TheFatEmperor | September 17, 2021

Did you see the recent hype on the latest cholesterol-lowering confection from Pharma? No data whatsoever to suggest it will improve heart disease outcomes, but UK NICE body has pronounced that billions will be spent on it regardless? Well here Dr. Aseem Malhotra and Dr. Malcolm Kendrick lay bare the latest lipid scam on GB news!

See also:

Inclisiran sneaks through under cover of COVID19

By Dr. Malcolm Kendrick | September 23, 2021

With all medical eyes on COVID19, a cardiovascular drug with no proven benefit – at all – has been approved by NICE (The UK National Institute for Health and Care Excellence). Once a drug is approved by NICE it can, and will, be prescribed by doctors in England and Wales and Northern Ireland.

… approving drugs, or launching drugs before you have any evidence that they do anything – other than having a favourable effect on an established lipid biomarker – is ridiculous. But never mind, longer term studies on Inclisiran will be completed by 2023, and 2026. When will they actually be published?

Who cares, by the time they are published, Inclisiran will have made billions, and no-one will care if the results are positive, or negative, as it will have become established as ‘standard’ treatment.

A number of us found the NICE approval of Inclisiran so ridiculous that we wrote them a letter. … Read full article

September 25, 2021 - Posted by | Corruption, Deception, Science and Pseudo-Science, Video | ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.